In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

The president has said the law is unfair to U.S. businesses. But lawyers say weakening it could end up costing corporate ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high ...

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced in a recent Form 8-K filing with the Securities and Exchange Commission that the company’s Board of Directors has scheduled its upcoming annual ...

We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...

Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...